Products

Tabula Rasa HealthCare Safety Campaign

October 15th 2020, were announced that Tabula Rasa HealthCare, Inc., a healthcare technology company advancing the field of medication safety, in collaboration with the American…


FDA Approves First Treatment for Ebola

On October 14, through immediate press-release FDA (Food and Druf Administration of U.S.) approved Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn), a mixture of three monoclonal antibodies,…



Humanigen And Thermo Fisher Deal

On September 23, media got the information about Humanigen and Thermo Fisher deal to scale up manufacturing of monoclonal antibody for COVID-19. To date Humanigen…


Acella Recalls Thyroid Medications

Acella Pharmaceuticals, LLC recalls recalling one lot of 15-mg and one lot of 120-mg NP Thyroid, Thyroid Tablets, USP [levothyroxine (T4) and liothyronine (T3)] to…



Catalent Investment And AZD1222 Vaccine

Catalent is one of the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer…


Hikma Launches Azacitidine

On September 10, Hikma Pharmaceuticals PLC (Hikma), at London announced Azacitidine for Injection, 100 mg, the generic version of Vidaza, in the United States it…


FDA Approval For RET Cancer Drug Gavreto

Recently FDA Okayed Gavreto (pralsetinib) for the treatment of adults with metastatic RET fusion-positive non-small cell lung cancer. Gavreto approved under the FDA’s accelerated approval…